Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
تاریخ نمایه سازی: 18 آذر 1398
چکیده مقاله:
نویسندگان
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
bSchool of Pharmacy, University of Waterloo, ۲۰۰ University Ave W., Waterloo, N۲L۳G۱, Canada. Waterloo Institute of Nanotechnology, University of Waterloo, ۲۰۰ University Ave W., Waterloo, N۲L۳G۱, Canada
School of Pharmacy, University of Waterloo, ۲۰۰ University Ave W., Waterloo, N۲L۳G۱, Canada Waterloo Institute of Nanotechnology, University of Waterloo, ۲۰۰ University Ave W., Waterloo, N۲L۳G۱, Canada. Mediphage Bioceuticals, Inc., ۶۶۱ University Avenue,
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran